Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis

ConclusionBoth in subjects with and without sarcoidosis, current expose to GC is associated with increased risk of major osteoporotic fractures, with no between-group difference. Sarcoidosis per se was not associated with increased fracture risk. Having sarcoidosis per se, i.e., if not treated with GC, is not a risk factor for fracture, and such patients may only need risk assessment when they commence GC therapy.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research